Biospecimen Sourcing & Data Sourcing Services
Access digital pathology data and biospecimens sourced through BioAI’s network of biobank and laboratory partners.
OUR SERVICE OFFERINGS
Gain Access to a Broad Range of Data and Biospecimen Samples
- Solid tumor blocks, plasma & peripheral blood
- Lung (NSCLC, SCLC), renal, colorectal, breast and other tumor types
- Archival and prospective collections
- Characterized via Pathology and Molecular analysis
- H&E and IHC stained digital pathology images
- Whole exome sequencing, NGS targeted panel
All specimens and data are de-identified and sourced by our partners under informed consent or IRB-approved protocols and data-use agreements.
Our Biospecimens & Digital Samples

Prospective, Custom Collections of Paired Samples
BioAI can collect paired samples of biofluids (plasma, urine, whole blood) with remnant FFPE tissue. Biofluid collection can be pre or post treatment.

H&E images and molecular characterization
BioAI offers H&E digital images, IHC and molecular characterization of FFPE samples.

Blood and Biofluids
BioAI has archival whole blood and plasma from cancer subjects and can set up prospective collections for individual needs.

Tissues
BioAI has FFPE resection and biopsies from rare and common tumor types, and other diseases.
Our Biospecimen & Data Sourcing Differentiators

Each sample can be characterized by pathology and molecular analysis.

BioAI can collect matched biospecimens (fluids and tissues) from individual subjects.

BioAI works with biobank partners across the US, Europe and Asia.

BioAI has a broad range of biospecimens for rare indications.
OUR RECENT PROJECTS
Customized Biospecimen Solutions to Meet Your Needs
- Prospective collection for plasma from subjects two years after resection. Collected plasma, whole blood and archival FFPE tissue from each subject
- Prospective collection for 12–16 mL of pre-surgical plasma, whole blood and matched FFPE resection tissue for multiple tumor types
- Procured 80+ FFPE tissue blocks and corresponding H&E images from rare tumor types. Client selected desired blocks after image review